Delivery Order SPE2DB24D1205-SPE2DB25FCZYG
- Not listed
- The Defense Logistics Agency awarded a $12,541.06 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with a completion date of July 31, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency (DLA) awarded a $35,072.01 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is listed...
- The Defense Logistics Agency awarded a delivery order valued at $67,384.37 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, which is firm fixed price with no set-aside designation, was competitively awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $52,149.01 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitive, non-set-aside contract carries a firm fixed price and was executed on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $27,208.93 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a $6,336.23 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The delivery order, which represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract (IDC) with DLA Troop Support Medical valued at $999,999,999, is scheduled for completion by August 11, 2025. The award was made through competitive procurement...
- The Defense Logistics Agency awarded a delivery order valued at $10,537.97 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,183.90 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency awarded a delivery order valued at $9,422.26 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors. The contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office operations. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors valued at $9,253.56 on July 30, 2025, with a completion date of July 31, 2025. This firm fixed price, non-competitive delivery order represents pharmaceutical procurement for military healthcare needs and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZYGDelivery Order
The Defense Logistics Agency awarded a $39,049.72 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. Enbrel is a biologic disease-modifying antirheumatic drug used primarily for treating autoimmune conditions such as rheumatoid arthritis and is an essential therapeutic product within the Defense Health Agency's medical supply chain. This delivery order reflects the company's ongoing role in fulfilling federal pharmaceutical requirements through open competition and demonstrates the operational efficiency of the DLA's Prime Vendor program in procuring specialized medical commodities for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.0k | 8/27/25 |